Results 111 to 120 of about 14,512,458 (287)
Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
Stroke, 2007 S. Mayer
semanticscholar +1 more source
Developmental, Neuroanatomical and Cellular Expression of Genes Causing Dystonia
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Dystonia is one of the most common movement disorders, with variants in multiple genes identified as causative. However, an understanding of which developmental stages, brain regions, and cell types are most relevant is crucial for developing relevant disease models and therapeutics.
Darren Cameron +5 more
wiley +1 more source
Remote Monitoring in Myasthenia Gravis: Exploring Symptom Variability
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background Myasthenia gravis (MG) is a rare, autoimmune disorder characterized by fluctuating muscle weakness and potential life‐threatening crises. While continuous specialized care is essential, access barriers often delay timely interventions. To address this, we developed MyaLink, a telemedical platform for MG patients.
Maike Stein +13 more
wiley +1 more source
Archives of pathology & laboratory medicine, 1993 Several prospective and cross-sectional studies have proposed that an association exists between elevated coagulation factor VII levels and cardiovascular disease. Not all of these studies used the same method to assess the factor VII levels. Although the most common method is the one-stage factor assay, there are numerous variables in the composition ...
T E, Hayes, J, Pike, R P, Tracy
openaire +1 more source
Proceedings of the National Academy of Sciences of the United States of America, 1977 Bjarne 0sterud +2 more
semanticscholar +1 more source
Variably Protease‐Sensitive Prionopathy: Two New Cases With Motor Neuron‐Dementia Syndrome
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT We describe two patients with variably protease‐sensitive prionopathy (VPSPr) who developed progressive upper motor neuron symptoms, insomnia, behavioral and cognitive decline, compatible with primary lateral sclerosis associated with frontotemporal dementia (FTD).
María Elena Erro +10 more
wiley +1 more source
Adult‐Onset Subacute Sclerosing Panencephalitis Presenting With Subacute Cognitive Deficits
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT We describe the case of a 41‐year‐old man diagnosed with adult‐onset subacute sclerosing panencephalitis (SSPE). The patient presented with subacute progressive cognitive deficits and a neuropsychological profile indicating predominant frontoparietal dysfunction. MRI showed only mild parietal‐predominant cerebral atrophy.
Dennis Yeow +4 more
wiley +1 more source
Development and Applications of Recombinant Activated Factor VII
Journal of Associated Medical Sciences, 2017 Recombinant activated factor VII (rFVIIa) was initially developed for treatment and prevention of bleeding during surgery and invasive procedures in congenital hemophilia with inhibitors against coagulation factors.
Nutjeera Intasai
doaj
Real‐World Performance of CSF Kappa Free Light Chains in the 2024 McDonald Criteria
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Kappa free light chains (KFLCs) in the cerebrospinal fluid (CSF) have a similar performance to CSF‐restricted oligoclonal bands (OCB) for multiple sclerosis (MS) diagnosis. To help with implementation, we set out to resolve several remaining uncertainties: (1) performance in a real‐world cohort and the 2024 McDonald criteria; (2 ...
Maya M. Leibowitz +11 more
wiley +1 more source
Is prophylaxis required for delivery in women with factor VII deficiency?
Haemophilia, 2013 L. M. Baumann Kreuziger +2 more
semanticscholar +1 more source